[Characteristics of Mycobacterium tuberculosis strains circulating in Pskov region]

Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec:(6):27-31.
[Article in Russian]

Abstract

Aim: Characteristics of drug resistance (DR) and population structure of Mycobacterium tuberculosis in Pskov region.

Materials and methods: In 90 strains of M. tuberculosis drug resistance was studied by culture method and by using "TB-BIOCHIP"; genotyping was determined by spoligotyping method.

Results: 55 (61.1%) of 90 M.tuberculosis strains had drug resistance, with 40 (44.4%) being multi-resistant. M. tuberculosis population was presented by SIT1 spoligotype strains of genetic families Beijing--44.4%, LAM--21.1%, T--14.4%, Haarlem--11.1% and Ural--5.6%, according to SpolDB4. Among M. tuberculosis strains circulating in Pskov region the most widespread (44.4%) was SIT1 spoligotype (p < 0.0001). DR and multi-resistant DR (MDR) in Beijing strains occurred more frequently than in "non-Beijing" strains (p < 0.001 and p = 0.03 respectively) and were determined by rpoB mutations Ser531-->Ley and katG Ser315-->Thr. All the SIT252 spoligotype strains were multi-resistant, and their resistance to rifampicin was determined by rpoB Asp516-->Ser substitution, to isoniazid --katG Ser315-->Thr and inhA_T15 substitutions.

Conclusion: The data obtained gives evidence on tuberculosis epidemiological unfavorability and wide circulation of MDR M. tuberculosis strains in Pskov region.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / therapeutic use
  • Bacterial Typing Techniques
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Female
  • Genes, Bacterial*
  • Genotype
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / therapeutic use
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mutation
  • Mycobacterium tuberculosis / classification
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / isolation & purification
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use
  • Russia / epidemiology
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin